A leading Caribbean Island destination to about 4 million travelers has recently been the focus of high-level travel advisories by the U.S. and U.K. governments.
Over 225,000 British nationals visited Jamaica annually before the recent pandemic.
On May 10, 2023, Jamaica, a member of the British Commonwealth, was issued a Level 3: Reconsider Travel advisory by the U.S. Department of State, which included numerous Do Not Travel notices for sections of Jamaica, including the capital city of Kingston, home to over 1.2 million people.
Jamaica Advisories Include 'Do Not Travel' Areas
A Different Type of RSV Vaccine
A clinical-stage synthetic biology company with a rational virus design platform for viral vaccines and immuno-oncology therapeutics today announced that it has initiated dosing in a pediatric Phase 1 study evaluating CodaVax™-RSV, a live-attenuated, intranasal vaccine candidate for the prevention of disease caused by the Respiratory Syncytial Virus (RSV).
First Lyme Disease Vaccine Licensed for Mice
The U.S. Department of Agriculture recently issued a Conditional Licensure for a novel oral vaccine against the wildlife spread of Borrelia burgdorferi, the bacterium responsible for Lyme disease.
Announced by US Biologic, Inc. on May 9, 2023, this innovative Borrelia Burgdorferi Bacterin vaccine is spray-coated onto pellets that mice consume.
As the expression goes, if you give a mouse a vaccine….. good things happen!
The only known vector of Lyme disease is blacklegged ticks, which are infected primarily by feeding on mammals, particularly white-footed mice.
Cancer Patients Give Telemedicine High Marks
Patient survey shows better ratings for access and provider concern with telemedicine versus in-person visits